ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,399, issued on March 25, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).
"Methods for achieving therapeutically effective doses of anti-CD47 agents" was invented by Stephen Willingham (Sunnyvale, Calif.), Maureen Howard (Los Altos Hills, Calif.), Jie Liu (Palo Alto, Calif.), Ravindra Majeti (Palo Alto, Calif.), Susan Sweeney Prohaska (Mountain View, Calif.), Anne Kathrin Volkmer (Duesseldorf, Germany), Jens-Peter Volkmer (Menlo Park, Calif.) and Irving L. Weissman (Stanford, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for treating a subject with a therapeutic dose of ...